About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Snord118em1Jfch
endonuclease-mediated mutation 1, Jian-Fu Chen
MGI:7738727
Summary 2 genotypes


Genotype
MGI:7782508
cn1
Allelic
Composition
Emx1tm1(cre)Krj/Emx1+
Snord118em1Jfch/Snord118+
Genetic
Background
B6.Cg-Emx1tm1(cre)Krj Snord118em1Jfch
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Emx1tm1(cre)Krj mutation (2 available); any Emx1 mutation (34 available)
Snord118em1Jfch mutation (0 available); any Snord118 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• at P20, body weight is significantly lower than in wild-type controls
• at E14.5, fetal body weight is significantly lower than in wild-type controls

nervous system
• at E14.5, brains show a significantly lower % of BrdU+ neural progenitor cells (NPCs) and p-H3+/Pax6+ apical neural progenitor cells (APCs) in the cortex ventricular zone/subventricular zone (VZ/SVZ) region than wild-type brains
• at E14.5 and P20, brain weight is significantly lower than in wild-type controls
• at E14.5, the cerebral cortex is significantly thinner than in wild-type brains
• at E14.5, brains show a significantly lower % of Pax6+ APCs and Tbr2+ intermediate neural progenitor cells (IPCs) in the cortex than wild-type brains

cellular
• an 5-ethynyl uridine (5-EU) incorporation assay showed a significantly lower 5-EU intensity in E12.5 cortex NPCs than in wild-type brains, indicating impaired rRNA synthesis
• at E14.5, brains show a significantly lower % of BrdU+ neural progenitor cells (NPCs) and p-H3+/Pax6+ apical neural progenitor cells (APCs) in the cortex ventricular zone/subventricular zone (VZ/SVZ) region than wild-type brains




Genotype
MGI:7782509
cn2
Allelic
Composition
Emx1tm1(cre)Krj/Emx1+
Snord118em1Jfch/Snord118em1Jfch
Genetic
Background
B6.Cg-Emx1tm1(cre)Krj Snord118em1Jfch
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Emx1tm1(cre)Krj mutation (2 available); any Emx1 mutation (34 available)
Snord118em1Jfch mutation (0 available); any Snord118 mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice are born at the expected Mendelian ratio but cannot survive beyond 1 month of age

growth/size/body
• at P20, body weight is markedly lower than in heterozygous mice and ~50% of that in wild-type mice
• at E14.5, fetal body weight is significantly lower than in wild-type controls but similar to that in heterozygous fetuses

nervous system
• at E12.5, brains show an aberrantly high % of p53+ cells in the cerebral cortex along with a significantly higher % of p21+/Sox2+ NPCs and Caspase-3+ cells in the VZ/SVZ regions than wild-type brains
• 2BAct treatment significantly reduces the %s of p-eIF2alpha+ cells and p53+ cells in the neocortex
• at E14.5, brains show an even greater reduction in the % of BrdU+ neural progenitor cells (NPCs) and p-H3+/Pax6+ APCs in the cortex ventricular zone/subventricular zone (VZ/SVZ) regions than heterozygous brains
• 2BAct treatment significantly increases the %s of BrdU+ cells in the neocortex
• at P20, mice lack most of the neocortex, hippocampus, and corpus callosum, indicating brain growth defects
• 2BAct treatment partially rescues the brain growth and ribosomopathy defects
• at E14.5, brain weight is even lower than in heterozygous fetuses, indicating a dose-dependent effect
• at P20, brain weight is markedly lower than in heterozygous mice and ~50% of that in wild-type mice
• daily i.p. injection of 2BAct (an integrated stress response inhibitor) in pregnant mice from E11.5 to E15.5 significantly mitigates brain weight loss at E16.5
• at P20, most of the corpus callosum is missing
• at P20, most of the hippocampus is missing
• at P20, most of the neocortex is missing
• at E14.5, the cerebral cortex is even thinner than in heterozygous brains
• 2BAct treatment partially rescues the reduction in cerebral cortex thickness
• at E14.5, brains show an even greater reduction in the % of Pax6+ apical neural progenitor cells (APCs) and Tbr2+ intermediate neural progenitor cells (IPCs) in the cerebral cortex than heterozygous brains
• neural progenitor cell (NPC) loss is due to ribosomopathy-like cellular defects, including p53 activation, cell cycle arrest, and apoptosis
• 2BAct treatment significantly increases the %s of Pax6+ APCs and Tbr2+ IPCs in the cerebral cortex

cellular
• an 5-ethynyl uridine (5-EU) incorporation assay showed an even greater reduction of 5-EU intensity in E12.5 cortex NPCs than in heterozygous brains, indicating a more severe defect in rRNA synthesis
• at E12.5, brains show an aberrantly high % of p53+ cells in the cerebral cortex along with a significantly higher % of p21+/Sox2+ NPCs and Caspase-3+ cells in the VZ/SVZ regions than wild-type brains
• 2BAct treatment significantly reduces the %s of p-eIF2alpha+ cells and p53+ cells in the neocortex
• at E14.5, brains show an even greater reduction in the % of BrdU+ neural progenitor cells (NPCs) and p-H3+/Pax6+ APCs in the cortex ventricular zone/subventricular zone (VZ/SVZ) regions than heterozygous brains
• 2BAct treatment significantly increases the %s of BrdU+ cells in the neocortex





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory